|
|
Previous Article | Table of Contents | Next Article 
Thrombospondin functions as a cytoadhesion molecule for human hematopoietic
progenitor cells
MW Long and VM Dixit
Department of Pediatrics, University of Michigan, Ann Arbor 48109.
We explored the role that thrombospondin (TSP), a multifunctional
extracellular matrix protein, plays in hematopoietic cell-cell and cell-
matrix interactions. Thrombospondin synthesis is differentially regulated
in human long-term bone marrow cultures. Consistent with this, human
hematopoietic progenitor cells of all three lineages (erythrocyte,
megakaryocyte, and granulocyte) use TSP as an attachment protein. However,
terminally differentiated cells (erythrocytes and neutrophils) show absent
or reduced attachment to TSP. The region within the TSP molecule that
mediates cell attachment (cell binding domain) was delineated by examining
both attachment to proteolytic fragments of TSP and by inhibition of
cytoadhesion using monoclonal antibodies directed against TSP domains. The
cell binding domain resides toward the C-terminus of a 140 Kd chymotryptic
fragment of TSP. We conclude that thrombospondin functions as a
hematopoietic cytoadhesion molecule, capable of binding primary
hematopoietic progenitor cells, and may, therefore, be important in blood
cell development.
Volume 75,
Issue 12,
pp. 2311-2318,
06/15/1990
Copyright © 1990 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Calzada, D. S. Annis, B. Zeng, C. Marcinkiewicz, B. Banas, J. Lawler, D. F. Mosher, and D. D. Roberts
Identification of Novel {beta}1 Integrin Binding Sites in the Type 1 and Type 2 Repeats of Thrombospondin-1
J. Biol. Chem.,
October 1, 2004;
279(40):
41734 - 41743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Cobankara, B. Oran, D. Ozatli, I. C. Haznedaroglu, A. Kosar, Y. Buyukasik, O. Ozcebe, S. Dundar, and S. Kirazli
Cytokines, Endothelium, and Adhesive Molecules in Pathologic Thrombopoiesis
Clinical and Applied Thrombosis/Hemostasis,
April 1, 2001;
7(2):
126 - 130.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gupta, T. R. Oegema Jr, J. J. Brazil, A. Z. Dudek, A. Slungaard, and C. M. Verfaillie
Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins
Blood,
January 1, 2000;
95(1):
147 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, H. Fjerdingstad, I. Strøm-Gundersen, and H. B. Benestad
Maturation Rate of Mouse Neutrophilic Granulocytes: Acceleration by Retardation of Proliferation, but No Detectable Influence from G-CSF or Stromal Cells
Stem Cells,
September 1, 1999;
17(5):
253 - 264.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. K. Nilsson, M. E. Debatis, M. S. Dooner, J. A. Madri, P. J. Quesenberry, and P. S. Becker
Immunofluorescence Characterization of Key Extracellular Matrix Proteins in Murine Bone Marrow In Situ
J. Histochem. Cytochem.,
March 1, 1998;
46(3):
371 - 378.
[Abstract]
[Full Text]
|
 |
|
|
|